Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,911 | -5,809 | -6,713 | -7,384 | -4,186 |
| Depreciation Amortization | 88 | 76 | 145 | 103 | 148 |
| Accounts receivable | -214 | -51 | 27 | -138 | 190 |
| Other Working Capital | 196 | 107 | 143 | -352 | 64 |
| Other Operating Activity | 1,392 | 718 | 516 | 2,891 | -204 |
| Operating Cash Flow | $-10,450 | $-4,959 | $-5,881 | $-4,879 | $-3,990 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -143 | N/A | N/A | N/A | N/A |
| PPE Investments | -25 | -43 | -34 | -49 | 273 |
| Purchase Sale Intangibles | -75 | -146 | -136 | -131 | -80 |
| Other Investing Activity | -75 | -146 | -136 | -131 | -80 |
| Investing Cash Flow | $-243 | $-189 | $-170 | $-181 | $194 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -23 |
| Debt Repayment | N/A | N/A | N/A | -45 | -44 |
| Common Stock Issued | 6,046 | 10,315 | 1,590 | 0 | 13,487 |
| Financing Cash Flow | $6,046 | $10,315 | $1,590 | $-45 | $13,420 |
| Exchange Rate Effect | -51 | -20 | N/A | N/A | N/A |
| Beginning Cash Position | 6,500 | 1,352 | 5,813 | 10,918 | 1,294 |
| End Cash Position | 1,802 | 6,500 | 1,352 | 5,813 | 10,918 |
| Net Cash Flow | $-4,698 | $5,148 | $-4,461 | $-5,105 | $9,624 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,450 | -4,959 | -5,881 | -4,879 | -3,990 |
| Capital Expenditure | -25 | -43 | -34 | -49 | N/A |
| Free Cash Flow | -10,475 | -5,002 | -5,915 | -4,929 | -3,990 |